forecast

GLP-1 Drugs May Cut Cardiovascular Risk 20-30%

Early studies of GLP-1 drugs suggest a 20% to 30% benefit against cardiovascular disease, the top US killer, so they could have the largest impact on American life expectancy in a very long time, though this will take time.

forecastpending

Speaker

Rod

Evidence Quote

“All the early studies we've seen so far from the GLPs say you're going to get 20% to 30% benefit.”

Source

RTW: Investing Across Healthcare— Business Breakdowns
Created: 11/13/2026, 1:54:32 PM

Your notes

Loading notes...